• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Clinical characteristics, diagnostic methods and results of surgically treated histologically benign cardiac myxomas
CONCLUSIONS: Myxomas are benign tumours, but they are serious pathologies that require early treatment because of signs of obstruction, embolic complications and confusion, with left atrial thrombus in the differential diagnosis.PMID:36752152 | DOI:10.5830/CVJA-2022-069
Source: Cardiovascular Journal of Africa - February 8, 2023 Category: Cardiology Authors: Durmu ş Alper Görür H üseyin Şaşkin Source Type: research

A case report of an ischaemic stroke, caused by a primary cardiac intimal sarcoma
We present a case of intimal sarcoma identified without any cardiac s...
Source: BMC Cardiovascular Disorders - February 1, 2023 Category: Cardiology Authors: Joshua Lloyd, Navinee Gilliat, Graeme Porter and Francesco Pirone Tags: Case Report Source Type: research

National outcomes following benign cardiac tumor resection: A critical sex ‐based disparity
ConclusionBenign atrial and ventricular tumors are uncommon, but disproportionately impact female patients, with female sex being an independent predictor of 30-day mortality. Root-cause analysis is necessary to determine the ultimate cause of this disparity.
Source: Journal of Cardiac Surgery - June 4, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Paige Newell, Cheryl K. Zogg, Jonathan Kusner, Sameer Hirji, Mariam Kerolos, Tsuyoshi Kaneko Tags: ORIGINAL ARTICLE Source Type: research

A systematic review of randomized clinical trials on the efficacy and safety of pitavastatin
Conclusion The FDA proven indications of pitavastatin are primary dyslipidemia and mixed dyslipidemia as adjunctive therapy to dietary changes to lower total cholesterol, LDL-C, apolipoprotein B (Apo B), triglycerides (TG), and to increase HDL-C. Pitavastatin might be suitable for subjects with diabetes, ACS (reduced revascularization), metabolic syndrome, CKD, HIV, and subjects with low levels of HDL-C. We highly recommend rational individualization for the selection of statin.PMID:35642121 | DOI:10.2174/2772432817666220531115314
Source: Pharmacological Reviews - June 1, 2022 Category: Drugs & Pharmacology Authors: Asim Ahmed Elnour Judit Don Azza Ramadan Adel Sadeq Abdulla Al Amoodi Kishore Gnana Sam Nadia Al Mazrouei Mohamed A Baraka Farah Hamad Farah Maisoun Alkaabi Source Type: research

Pages: 1  2  3  4